How have AIMD and JSPR total returns compared?

Over the past 5 years, AIMD delivered -58.50% and JSPR delivered -62.51% annualized total return. Past performance doesn't predict future results.

Ainos, Inc. (AIMD) vs Jasper Therapeutics, Inc. (JSPR)

A side-by-side comparison of Ainos, Inc. and Jasper Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

AIMD

Ainos, Inc.

$10M

$1.33HealthcareDelayed quote: Oct 6, 2026, 11:28 AM EDT

JSPR

Jasper Therapeutics, Inc.

$9M

$0.57HealthcareDelayed quote: Oct 6, 2026, 11:28 AM EDT

Total return — AIMD vs JSPR

growth of $100 · dividends reinvested · last 6y

AIMD -97.7% (-46.6%/yr)JSPR -99.4% (-57.6%/yr)AIMD compounded faster over this window

AIMD JSPR

AIMD vs JSPR: by the numbers

•AIMD is the larger company ($10M vs $9M market cap).
•Both run net losses; JSPR's is the smaller (0.00% vs -106283.32% net margin).

Metrics side by side

Valuation

Metric	AIMD	JSPR
P/S ratio	720.26	N/A
P/B ratio	2.98	6.60

Profitability

Metric	AIMD	JSPR
Gross margin	-3767.20%	0.00%
Operating margin	-11268.32%	0.00%
Net margin	-106283.32%	0.00%
ROE	-440.15%	-2248.48%
ROIC	-80.51%	-1394.09%

Growth (annualized)

Metric	AIMD	JSPR
Revenue CAGR (5Y)	49.62%	N/A
Total return CAGR (5Y)	-58.50%	-62.51%

Frequently asked

How have AIMD and JSPR total returns compared?: Over the past 5 years, AIMD delivered -58.50% and JSPR delivered -62.51% annualized total return. Past performance doesn't predict future results.

Go deeper

Full AIMD analysis Full JSPR analysis Interactive comparison tool

Dig into the metrics

Ainos ROE Jasper Therapeutics ROE Ainos operating margin Jasper Therapeutics operating margin Ainos revenue growth Jasper Therapeutics revenue growth Ainos free cash flow Jasper Therapeutics free cash flow

Ainos & Jasper Therapeutics appear in these rankings

Fastest Revenue Growth Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.